THC THERAPEUTICS, INC.
CIK 0001404935
Revenue (TTM)
$0
FY Feb 2026
Net Income (TTM)
−$435.48K
−109.7% YoY
FY Feb 2026
EPS Diluted (TTM)
—
FY Feb 2026
Gross Margin
—
FY Feb 2026
Operating Margin
—
FY Feb 2026
Net Margin
—
FY Feb 2026
Free Cash Flow (TTM)
—
FY Feb 2026
Cash
$35
FY Feb 2026
Total Debt
—
FY Feb 2026
Shares Outstanding
40.27M sh
FY Feb 2026
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.